Peer-Reviewed Independent Study Published In Microbiology Spectrum Finds Cue Health's Molecular COVID-19 Test Is As Accurate As A Lab-Based PCR Test
Portfolio Pulse from Benzinga Newsdesk
Cue Health's molecular COVID-19 test has been found to be as accurate as a lab-based PCR test, according to a peer-reviewed independent study published in Microbiology Spectrum. The study found that Cue's test had a 99.4% match with lab-based PCR tests and 100% clinical sensitivity to detect positive cases. Cue Health recently received De Novo authorization from the FDA for its COVID-19 test.
October 04, 2023 | 1:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cue Health's COVID-19 test has been found to be as accurate as a lab-based PCR test, which could increase its market appeal. The company recently received FDA De Novo authorization for the test.
The positive results of the study could increase the market appeal of Cue Health's COVID-19 test, potentially leading to increased sales and revenue. The recent FDA De Novo authorization could also boost the company's credibility and market position.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100